Abstract
On 18 September 2012, health authorities began to react to a multistate outbreak of fungal meningitis of unprecedented magnitude, traceable to 3 lots of preservative-free methylprednisolone compounded in one pharmacy ([1][1]). The steroids had been used mostly for epidural injection, largely causing
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
